Xvivo Perfusion AB (publ) (STO:XVIVO)
299.50
-12.00 (-3.85%)
Mar 28, 2025, 5:29 PM CET
Xvivo Perfusion AB Revenue
In the year 2024, Xvivo Perfusion AB had annual revenue of 822.42M SEK with 37.63% growth. Xvivo Perfusion AB had revenue of 227.56M in the quarter ending December 31, 2024, with 46.12% growth.
Revenue
822.42M
Revenue Growth
+37.63%
P/S Ratio
11.47
Revenue / Employee
4.84M
Employees
170
Market Cap
9.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 822.42M | 224.87M | 37.63% |
Dec 31, 2023 | 597.54M | 182.25M | 43.88% |
Dec 31, 2022 | 415.29M | 156.91M | 60.73% |
Dec 31, 2021 | 258.39M | 78.53M | 43.66% |
Dec 31, 2020 | 179.86M | -40.98M | -18.55% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition